Evidence map›Paper›PMID 34424902›Full record

Trial reportPloS one2021

Cognitive decline in Huntington's disease in the Digitalized Arithmetic Task (DAT).

Marine Lunven, Jennifer Hamet Bagnou, Katia Youssov, Alexis Gabadinho, Rafika Fliss, Justine Montillot, Etienne Audureau, Blanche Bapst, Graça Morgado, Ralf Reilmann and 6 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Marine LunvenDépartement d'Etudes Cognitives, École normale supérieure, PSL University, Paris, France.ORCID 0000-0002-9431-5980
Jennifer Hamet BagnouDépartement d'Etudes Cognitives, École normale supérieure, PSL University, Paris, France.
Katia YoussovDépartement d'Etudes Cognitives, École normale supérieure, PSL University, Paris, France.
Alexis GabadinhoDépartement d'Etudes Cognitives, École normale supérieure, PSL University, Paris, France.
Rafika FlissDépartement d'Etudes Cognitives, École normale supérieure, PSL University, Paris, France.
Justine MontillotDépartement d'Etudes Cognitives, École normale supérieure, PSL University, Paris, France.
Etienne AudureauClinical Epidemiology and Ageing, Service de santé publique, Henri Mondor Hospital, AP-HP, Créteil, France.
Blanche BapstDepartment of Neuroradiology, AP-HP, Henri Mondor University Hospital, Créteil, France.
Graça MorgadoCentre d'Investigation Clinique, Hôpital Henri Mondor, Créteil, France.
Ralf ReilmannGeorge-Huntington-Institute, Technology-Park, Muenster, Germany.ORCID 0000-0002-5904-9517
Robin SchubertGeorge-Huntington-Institute, Technology-Park, Muenster, Germany.
Monica BusseCentre for Trials Research, Cardiff University, United Kingdom.
David CraufurdManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Renaud MassartDépartement d'Etudes Cognitives, École normale supérieure, PSL University, Paris, France.
Anne RosserNMHRI, School of Medicine, and Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-4716-4753
Anne-Catherine Bachoud-LéviDépartement d'Etudes Cognitives, École normale supérieure, PSL University, Paris, France.
Inserm · FRCardiff University · GBAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire Henri-Mondor · FRGeorge Huntington Institute · DEManchester Academic Health Science Centre · GBUniversité Paris-Est Créteil · FRUniversity of Münster · DE

Funding

Medical Research Council MR/L010305/1Medical Research Council MR/T033428/1
6 · The paper itself

Abstract

backgroundEfficient cognitive tasks sensitive to longitudinal deterioration in small cohorts of Huntington's disease (HD) patients are lacking in HD research. We thus developed and assessed the digitized arithmetic task (DAT), which combines inner language and executive functions in approximately 4 minutes.

methodsWe assessed the psychometric properties of DAT in three languages, across four European sites, in 77 early-stage HD patients (age: 52 ± 11 years; 27 females), and 57 controls (age: 50 ± 10, 31 females). Forty-eight HD patients and 34 controls were followed up to one year with 96 participants who underwent MRI brain imaging (HD patients = 46) at baseline and 50 participants (HD patients = 22) at one year. Linear mixed models and Pearson correlations were used to assess associations with clinical assessment.

resultsAt baseline, HD patients were less accurate (p = 0.0002) with increased response time (p<0.0001) when compared to DAT in controls. Test-retest reliability in HD patients ranged from good to excellent for response time (range: 0.63-0.79) and from questionable to acceptable for accuracy (range: r = 0.52-0.69). Only DAT, the Mattis Dementia Rating Scale, the Symbol Digit Modalities Test, and Total Functional Capacity scores were able to detect a decline within a one-year follow-up in HD patients (all p< 0.05). In contrast with all the other cognitive tasks, DAT correlated with striatal atrophy over time (p = 0.037) but not with motor impairment.

conclusionsDAT is fast, reliable, motor-free, applicable in several languages, and able to unmask cognitive decline correlated with striatal atrophy in small cohorts of HD patients. This likely makes it a useful endpoint in future trials for HD and other neurodegenerative diseases.

Indexed as

BrainCognitive DysfunctionHuntington DiseaseMagnetic Resonance ImagingNeuroimagingAdultExecutive FunctionFemaleHumansLanguageLongitudinal StudiesMaleMiddle AgedNeuropsychological TestsPsychometrics

Identifiers

PMID34424902
PMCPMC8382187
OpenAlexW3168857045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.